|
Tomas Lindahl
Mutagenesis Laboratory
London Research Institute
Clare Hall Laboratories
Blanche Lane
South Mimms
Herts EN6 3LD
Research Goals
By definition of the mechanisms and efficiencies of DNA repair processes, we aim to clarify cellular resistance to carcinogens, as well as elucidate the acquired drug and radiation resistance that often emerges in cancer patients.
Qualifications and Personal History
MD 1970 Karolinska Institute, Stockholm.
Postdoctoral work at Princeton University and Rockefeller University, USA.
Joined Imperial Cancer Research Fund (now known as Cancer Research UK) in 1981.
|
|
|